BSEResult2d ago · 23 Oct 2026, 04:27 pm

Outcome of the Board Meeting held on Friday, October 23, 2026

Jupiter Life Line Hospitals Ltd · 543980

✦ AI SummaryResults

Jupiter Life Line Hospitals Ltd has announced its unaudited financial results for the quarter and half year ended September 30, 2026, along with the incorporation of a wholly owned subsidiary and the acquisition of land for ₹150 Crores.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Jupiter Life Line Hospitals Ltd - 543980 - Unaudited Financial Results (Standalone & Consolidated) For Quarter And Half Year Ended September 30, 2026

Attachments (1)

📄

60414cad-2faf-4885-b242-76a98f71d345.pdf

pdf

Download →
View document text
October 23, 2026 To, To, National Stock Exchange of India Ltd. BSE Limited Exchange Plaza, BKC P.J. Towers, Bandra-Kurla Complex, 25th Floor, Dalal Street, Fort Bandra (East), Mumbai-400 051 Mumbai 400 001 Symbol: JLHL Code: 543980 Subject: Outcome of the Board Meeting held on Friday, October 23, 2026 Dear Sir/Madam, In furtherance to our intimation dated October 08, 2026, this is to inform you that pursuant to Regulations 30, 33, and Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), the Board of Directors of the Company at its Meeting held today, i.e., October 23, 2026, has inter-alia: - a) Considered and approved the Unaudited Financial Results (both standalone and consolidated basis) for the quarter and half year ended on September 30, 2026 along with the Limited Review Report. A copy of the said Results is enclosed herewith as Annexure – I. b) Considered and approved the incorporation of a wholly owned subsidiary of the Company. The details as required in terms of SEBI Listing Regulations and SEBI Master Circular dated January 30, 2026 are enclosed herewith as Annexure – II. c) With reference to our announcement dated February 22, 2026 regarding acquisition of land on lease at South Pune, and further to the same, the company is entering into a sale agreement for the acquisition of land admeasuring to ~11,452.07 square metres, situated at Village Pune City (Bibvewadi), District Pune, for a total consideration of ₹150 Crores. The requisite disclosures as per Regulation 30 of Listing Regulations read with Circular dated January 30, 2026 (‘SEBI Circular’) is enclosed as Annexure-III. The Board meeting commenced at 3:00 P.M. and was conclude at 3.43 P.M. The aforementioned information will be available at the website of the Company at www.jupiterhospital.com You are requested to kindly take the afore mentioned on record and oblige. Thanking you, For JUPITER LIFE LINE HOSPITALS LIMITED Suma Upparatti Company Secretary & Compliance Officer Encl: As stated above Annexure I KKC & Associates LLP Aswin P. Malde & Co. Chart€red Accountants Chartered Accountants (formerly Khimji Kunverji & Co LLP) Sunshine Tower, Level 19 405, Jay Commercial Plaza, Senapati Bapat Marg Junction of S.L. Road & M.G, Road, Elphinstone Road Mutund (W), Mumbai-400 013 Mumbai- 400 080 Telephone: +91 22 5143 7333 Telephone: +91 22 6552 5689 lndependent Auditor's Review Report on unaudited standalone financial results for the quarter ended 30 September 2025 and year to date results for the period from 01 April 2026 to 30 September 2026 of Jupiter Life Line Hospitals Limited under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. The Board of Directors of Jupiter Life Line Hospitals Limited lntroduction We have reviewed the accompanying statement of unaudited standatone financial results of Jupiter Life Line Hospitals Limited ('the Company') for the quarter ended 30 September 2026 and year to date results for the period from 0l April 2025 to 30 September2026 ('the Statement'), being submitted bythe Company pursuant to the requirements of Regulation 33 of the Securities and Exchange Board of lndia (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ('Listing Regulations'). We have initiatled the Statement for identification purpose only. This Statement, which is the responsibility of the Company's Management and approved by the Board of Directors ofthe Company, has been prepared in accordance with the recognition and measurement principles laid down in the lndian Accounting Standard ('lnd AS') 34'lnterim Financial Reporting' specified in section 133 of the Companies Act, 2013 ('the Act'), read with relevant rules issued thereunder and other accounting principtes generally accepted in lndia and in comptiance with Regulation 33 of the Listing Regulations. Our responsibility is to express a conctusion on the Statement based on our review. Scope of Review We conducted our review ofthe Statement in accordance with the Standard on Review Engagements ('SRE') 2410 -'Review of lnterim Financiatlnformation Performed by the lndependent Auditor ofthe Entity'issued by the lnstitute of Chartered Accountants of lndia ('the lCAl'). This standard requires that we plan and perform the review to obtain moderate assurance as to whether the Statement is free of material misstatement. A review is limited primarilyto inquiries of company's personneLand analyticatprocedures apptied to financial data and thus provides less assurance than an audit. We have not performed an audit and accordingty, we do not express an audit opinion. Conclusion Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in lnd AS, specified under Section 133 of the Act as a mended, read with releva nt rules issued thereu nder and other accounting principles generally accepted in lndia has not disctosed the information required to be disclosed in terms of Regulation 33 of the Listing Regulations, including the manner in which it is to be disclosed, or that it contains any materiat misstatement. ? MAT F.R.N. osSo 100725W KKC & Associates ILP Aswin P. Malde & Co, Chartered Accountants Chartered Accountants (formerly Khimji Kunverji & Co LLP) Sunshine Towet Level 19 405, Jay Commercial Plaza, Senapati Bapat Marg Junction of S.L. Road & M.G, Road, Etphinstone Road Mutund (W), Mumbai-400 013 Mumbai- 400 080 Telephone: +91 22 6143 7333 Telephone: +91 22 6552 5589 Other Matter The Standalone financiat results include the financiaI information of 1 (one) partnership firm whose financial information being certified by the Management, reflects the Company's share of net loss after tax of Rs. 2.73 mitlion and Rs.5.97 million for the quarterended 30 September 2026 and forthe period from 0l April2026 to 30 September 2026 respectively, as considered in the Statement. According to the information and explanations given to us by the Management, these fi na nciaI information are not material to the Company. Ou r conclusion on the Statement is not modified in respect of the above matter. For KKC & Associates LLP For Aswin P. Malde & Co Chartered Accou ntants Chartered Accountants (formerly Khimji Kunverji & Co LLP) Firm Registration Number: 100725W Firm Registration Number: 105146W/W100621 VM- ASSO F.R.N. Hasmukh B Dedhia Aswin P. Malde 10 $0725W Pa rtn er Proprietor lCAl Membership No: 033494 * lCAl Membership No: 032662 UDIN: 260349+tok H 6\1u 2?2 | UDIN: {6326g26tFf BNM t83o Ptace: Mumbai Place: l\4umbai Date: 23 October 2025 Date: 23 October 2025 JUPITER T!FE LINE HOSPITA6IIMITED Resirrered Ofti.e:1004,loth floo Cr,' o3 t6 P0 o rD at€t ere O€ fficB !: ut Ein ane ett rc - ntl " tt x: ri pa : r5 evr sO l eiO t HM "" iu thi2 w00 at2 v"P ' "l TC p h1 a 3 nO7 e9 'o0 {ww8 k )'' l_ M8 as h M ara t& h vM t u _l 4u 0n od ( 6w 01)' Murnbai' Mahatashlla _400080 TelePhon. Nor022 62976630 EmaiI info@iuPiterhoePital'con w€brwww'jup te'hospital'com STATEMENTOF UN AI,,DITEO STAN OALON E flNANCIAL iESULI! TOiTHEQUAAIER ANO HAIT YEAi ENOEO SEPTEMBER 30' 2025 tratf vsEnaea Ended lo26 - -Yeai 1. Revenue nom oP€rations 1,6 64 85 .. 99 27 3,2 18 04 6. .8 45 3 3,1 15 18 3. .1 06 9 6,9 13 70 5. 18 52 5,9 23 48 1. .0 43 5 t7,9 47 26 2.2 .54 t 3,774.89 3,391.28 3,271.25 1,106,17 6,179.48 12,:t98.7s cP hu .. n(h ga es re 5 i n o inl vm ee nd tr oc ra il e !c o on f t mum eda ltb ale l t c, od nr tu uE m .a bn led s t ,u drg ruc Sa !l an ne dm! 51 14 7. .8 13 4 588 7 .39 53 55 (9 s. .3 24 s) 7,20 23 4. .7 76 0 1.o1 {0 8. .5 97 8) 2 (, 12 03 16 .. 4r8 0) Emrloyee benef t exPente 6 82 77 3. .8 15 5 85 06 4t. .5 04 6 4 88 34 3- .65 14 1 1, ,1 69 77 7. .3 29 2 !,49 t5 78 .. 64 93 2 2, ,0 85 66 {.. 939 9 90.42 81.16 29.63 171.58 59.64 r28.15 Oepre.ialion and amorlitation e [Showing first 8,000 characters — download PDF for full document]